Revolution Medicines Officer Anthony Mancini Files Form 144 to Sell $484K in Common Stock

Executive Summary

On September 15, 2026, Anthony Mancini, an Officer at Revolution Medicines, Inc. (NASDAQ: RVMD), filed a Form 144 notice proposing the sale of 2,377 shares of Common Stock with an aggregate market value of approximately $484,361.29. The securities were acquired on the same date via an RSU vesting event.

Transaction Details

• Security: Common Stock
• Proposed Sale Volume: 2,377 shares
• Aggregate Market Value: $484,361.29
• Estimated Price per Share: ~$203.77
• Acquisition Nature: RSU vesting (Services rendered)
• Broker: ETRADE Financial Corporation
• Shares Outstanding: 214,336,418 shares

Prior Sales in Past 3 Months

• September 10, 2026: 15,448 shares sold for gross proceeds of $3,153,806.67
• June 16, 2026: 4,615 shares sold for gross proceeds of $720,490.11

Market Impact & Significance

The trading significance is assessed as Low. The transaction size represents a negligible percentage (<0.01%) of the company's total shares outstanding and coincides directly with RSU vesting, typical of routine equity compensation management or sell-to-cover tax obligations.